Comparative Efficacy of Disease-Modifying Treatments for Relapsing Multiple Sclerosis-Variations in Real-World Experience

JAMA Neurol. 2024 Jan 1;81(1):87. doi: 10.1001/jamaneurol.2023.4395.
No abstract available

MeSH terms

  • Humans
  • Immunosuppressive Agents
  • Multiple Sclerosis*
  • Multiple Sclerosis, Relapsing-Remitting* / drug therapy
  • Recurrence

Substances

  • Immunosuppressive Agents